KKR & Co. (KKR) Appoints Oliver Johansen to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
KKR Closes Acquisition of Clinisupplies and Welcomes Oliver Johansen to the Board of Directors
January 18, 2023 3:00 AM ESTKKR to support organic and inorganic growth to enhance Clinisupplies leadership position in collecting devices and expand its broader chronic care portfolio
 Oliver Johansen, former Senior Vice President, Global Research and Development at Coloplast, to join KKR Senior Advisor and former Chief Executive Officer of Atos Medical AB, Claus Bjerre, and industry veteran, Douglas Le Fort on Clinisupplies Board of Directors
LONDON--(BUSINESS WIRE)-- KKR, a leading global investment firm, announced today the closing of KKRs previously announced investment in Clinisupplies, a market leader in continence care products... More
